CMRR investigators apply our developed technologies to imaging cancer. The breast group focuses on diffusion imaging methodology and integrating these methods into clinical trials of treatment response. The prostate team uses UHF acquisitions and quantitative methods for active surveillance. Our investigators also use MR spectroscopy to detect 2-HG mutations in brain gliomas and use this information to guide therapy selection.
Cancer and Treatment Response Publications body